Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2022-07-22 History
Report ID 153842
Drug Identification Number 02401339
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.5G 4G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4.5G VIAL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-01-28
Estimated end date
Actual end date 2022-07-21
Shortage status Resolved
Updated date 2022-07-22
Company comments To be discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-01-28 English Compare
v2 2022-01-28 French Compare
v3 2022-01-29 English Compare
v4 2022-07-21 English Compare
v5 2022-07-21 French Compare
v6 2022-07-22 English Compare

Showing 1 to 6 of 6